Skip to main content

Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001658247

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Crinetics Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $120.0K in total
Insiders trading
1
Net value
−$120.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Crinetics Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Crinetics Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wierenga WendellDirector0Sep 1, 20262
Vivaldi Coelho RogerioDirector0Sep 1, 20264
Okey StephanieDirector0Sep 1, 20264
Nichols WestonDirector0Sep 1, 20262
Fust Matthew KDirector0Sep 1, 20263
Deardorf CarenDirector0Sep 1, 20262
Bedrosian Camille LDirector0Sep 1, 20262
Kalofonos IsabelChief Commercial Officer0Sep 1, 20263
Betz Stephen F.Chief Scientific Officer0Sep 1, 20264
Schilke TobinChief Financial & Infra. Ofcr.0Sep 1, 20264
Struthers Richard ScottPresident & CEO0Sep 1, 20267
Knight Jeff E.Chief Dev. & Operating Officer105,289Apr 10, 20263
Pizzuti DanaChief Med and Dev Officer66,837Dec 3, 20253
Wierenga WendallDirector116,146Jun 13, 20250
Wilson MarcCFO111,092Sep 30, 20240
Hassard JamesChief Commercial Officer29,259Jul 9, 20240
Krasner Alan SethChief Medical Officer43,210Oct 19, 20230
Edelman Joseph10% Owner5,321,032IndirectApr 18, 20220
Perceptive Advisors LLC10% Owner5,321,032IndirectApr 18, 20220
Perceptive Life Sciences Master Fund Ltd10% Owner5,321,032IndirectApr 18, 20220
Madan AjayChief Development Officer176,995Mar 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 7, 2026 (view filing)4:30 PM ETJul 25 daysVivaldi Coelho RogerioDirectorSSale−3.00K$40.00−$120.0K−13.5%19.2K after10b5-1
Jun 18, 2026 (view filing)Jun 171 dayOkey StephanieDirectorSSale−6.90K$35.67−$246.1K−51.9%6.40K after2 lots10b5-1
Apr 10, 2026 (view filing)Apr 82 daysKnight Jeff E.Chief Dev. & Operating OfficerSSale−85.2K$40.10−$3.42M−44.7%105.3K after10b5-1
Mar 18, 2026 (view filing)Mar 162 daysKnight Jeff E.Chief Operating OfficerSSale−9.91K$37.37−$370.4K−8.1%112.0K after2 lots10b5-1
Mar 18, 2026 (view filing)Mar 162 daysBetz Stephen F.Chief Scientific OfficerSSale−10.6K$37.37−$396.6K−7.2%137.1K after2 lots10b5-1
Mar 18, 2026 (view filing)Mar 162 daysStruthers Richard ScottPresident & CEOSSale−22.0K$37.37−$821.5K−5.2%404.8K after2 lots10b5-1
Mar 13, 2026 (view filing)Mar 121 dayVivaldi Coelho RogerioDirectorSSale−5.00K$36.15−$180.8K−23.5%16.3K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 31 dayOkey StephanieDirectorSSale−3.00K$39.67−$119.0K−18.4%13.3K after10b5-1
Mar 4, 2026 (view filing)Mar 31 daySchilke TobinChief Financial OfficerSSale−6.71K$39.67−$266.3K−7.9%78.1K after10b5-1
Jan 7, 2026 (view filing)Jan 52 daysKalofonos IsabelChief Commercial OfficerSSale−2.50K$55.00−$137.5K−75.0%834 after10b5-1
Dec 3, 2025 (view filing)Dec 12 daysPizzuti DanaChief Med and Dev OfficerSSale−5.00K$45.02−$225.1K−7.0%66.8K after10b5-1
Nov 5, 2025 (view filing)Nov 32 daysPizzuti DanaChief Med and Dev OfficerSSale−5.00K$42.66−$213.3K−7.0%66.3K after2 lots10b5-1
Oct 3, 2025 (view filing)Oct 12 daysPizzuti DanaChief Med and Dev OfficerSSale−5.00K$41.81−$209.1K−7.0%66.3K after10b5-1
Sep 30, 2025 (view filing)Sep 264 daysStruthers Richard ScottPresident & CEOSSale−4.00K$45.00−$180.0K−3.6%106.0K after10b5-1
Sep 30, 2025 (view filing)Sep 264 daysFust Matthew KDirectorSSale−16.0K$44.75−$716.0K−41.2%22.8K after10b5-1
Sep 4, 2025 (view filing)Sep 22 daysPizzuti DanaChief Med and Dev OfficerSSale−5.00K$32.10−$160.5K−4.9%96.3K after10b5-1
Aug 26, 2025 (view filing)Aug 224 daysPizzuti DanaChief Med and Dev OfficerSSale−30.0K$30.43−$912.9K−31.2%66.3K after10b5-1
Aug 21, 2025 (view filing)Aug 201 dayPizzuti DanaChief Med and Dev OfficerSSale−6.49K$29.18−$189.4K−8.9%66.3K after10b5-1
Jun 16, 2025 (view filing)Jun 124 daysBetz Stephen F.Chief Scientific OfficerSSale−97.5K$32.23−$3.14M−49.4%99.7K after10b5-1
Mar 21, 2025 (view filing)Mar 192 daysPizzuti DanaChief Med and Dev OfficerSSale−2.52K$34.20−$86.0K−3.4%72.2K after2 lots10b5-1
Mar 21, 2025 (view filing)Mar 192 daysKnight Jeff E.Chief Operating OfficerSSale−7.16K$34.20−$245.0K−7.6%87.5K after2 lots10b5-1
Mar 21, 2025 (view filing)Mar 192 daysBetz Stephen F.Chief Scientific OfficerSSale−5.77K$34.20−$197.4K−5.0%108.6K after2 lots10b5-1
Mar 21, 2025 (view filing)Mar 192 daysStruthers Richard ScottPresident & CEOSSale−17.3K$34.20−$593.0K−5.0%329.1K after2 lots10b5-1
Feb 5, 2025 (view filing)Feb 32 daysPizzuti DanaChief Med and Dev OfficerSSale−5.00K$39.07−$195.3K−13.6%31.7K after10b5-1
Jan 7, 2025 (view filing)Jan 34 daysPizzuti DanaChief Med and Dev OfficerSSale−15.0K$52.09−$781.4K−33.9%29.2K after10b5-1
Dec 4, 2024 (view filing)Dec 22 daysStruthers Richard ScottPresident & CEOSSale−10.0K$57.57−$575.7K−9.1%100.0K after10b5-1
Nov 26, 2024 (view filing)Nov 224 daysKnight Jeff E.Chief Operating OfficerSSale−501$56.52−$28.3K−1.0%51.7K after10b5-1
Oct 7, 2024 (view filing)Oct 34 daysPizzuti DanaChief Med and Dev OfficerSSale−14.4K$54.63−$785.3K−33.5%28.5K after10b5-1
Sep 30, 2024 (view filing)Sep 264 daysWilson MarcCFOSSale−25.0K$51.11−$1.28M−18.4%111.1K after10b5-1
Sep 12, 2024 (view filing)Sep 102 daysBetz Stephen F.Chief Scientific OfficerSSale−1.03K$51.50−$53.3K−1.5%68.6K after10b5-1
Aug 28, 2024 (view filing)Aug 262 daysBetz Stephen F.Chief Scientific OfficerSSale−3.00K$53.19−$159.6K−4.1%69.6K after10b5-1
Aug 14, 2024 (view filing)Aug 122 daysBetz Stephen F.Chief Scientific OfficerSSale−3.00K$47.68−$143.0K−4.0%72.6K after10b5-1
Jul 26, 2024 (view filing)Jul 251 dayBetz Stephen F.Chief Scientific OfficerSSale−3.00K$53.43−$160.3K−3.8%75.6K after10b5-1
Jul 26, 2024 (view filing)Jul 251 dayWilson MarcCFOSSale−19.1K$53.88−$1.03M−14.6%111.1K after10b5-1
Jul 17, 2024 (view filing)Jul 152 daysKnight Jeff E.Chief Operating OfficerSSale−27.0K$55.00−$1.49M−34.3%51.7K after10b5-1
Jul 17, 2024 (view filing)Jul 152 daysWilson MarcCFOSSale−25.0K$55.00−$1.38M−18.4%111.1K after10b5-1
Jul 12, 2024 (view filing)Jul 102 daysBetz Stephen F.Chief Scientific OfficerSSale−3.00K$48.55−$145.7K−3.7%78.6K after10b5-1
Jul 9, 2024 (view filing)Jul 54 daysHassard JamesChief Commercial OfficerSSale−15.0K$44.08−$661.2K−33.9%29.3K after10b5-1
Jul 5, 2024 (view filing)Jul 32 daysPizzuti DanaChief Med and Dev OfficerSSale−14.4K$44.87−$645.0K−33.5%28.5K after10b5-1
Jul 2, 2024 (view filing)Jun 284 daysWilson MarcCFOSSale−32.1K$43.61−$1.40M−22.4%111.1K after10b5-1
Jun 28, 2024 (view filing)Jun 262 daysKnight Jeff E.Chief Operating OfficerSSale−956$44.38−$42.4K−1.8%52.6K after10b5-1
Jun 26, 2024 (view filing)Jun 251 dayBetz Stephen F.Chief Scientific OfficerSSale−3.00K$45.37−$136.1K−3.6%80.6K after10b5-1
Jun 25, 2024 (view filing)Jun 241 dayPizzuti DanaChief Med and Dev OfficerSSale−9.50K$45.73−$434.4K−25.5%27.8K after
Jun 24, 2024 (view filing)Jun 213 daysHassard JamesChief Commercial OfficerSSale−15.0K$44.66−$669.9K−33.9%29.3K after10b5-1
Jun 11, 2024 (view filing)Jun 101 dayBetz Stephen F.Chief Scientific OfficerSSale−3.00K$43.86−$131.6K−3.5%83.6K after10b5-1
May 30, 2024 (view filing)May 282 daysBetz Stephen F.Chief Scientific OfficerSSale−3.00K$47.49−$142.5K−3.3%86.6K after10b5-1
May 14, 2024 (view filing)May 104 daysBetz Stephen F.Chief Scientific OfficerSSale−3.00K$49.43−$148.3K−3.2%89.6K after10b5-1
May 10, 2024 (view filing)May 82 daysStruthers Richard ScottPresident & CEOSSale−107.4K$49.40−$5.31M−29.4%257.5K after10b5-1
Apr 17, 2024 (view filing)Apr 152 daysPizzuti DanaChief Med and Dev OfficerSSale−14.4K$44.47−$639.3K−34.1%27.8K after10b5-1
Apr 8, 2024 (view filing)Apr 44 daysStruthers Richard ScottPresident & CEOSSale−41.0K$49.17−$2.01M−14.7%237.8K after10b5-1